CHMP Adopts Positive Opinion for Aflibercept, Pegfilgrastim Biosimilars: On January 30, 2025, the European Medicines Agency (EMA) Committee ...
Blood Grouping Reagents Market Growth is Driven by Automated Blood Typing Systems and Rising Demand in Transfusion Medicine.Austin, United States, Feb. 07, 2025 (GLOBE NEWSWIRE) -- According to SNS ...
This article is authored by Ranjit Barshikar, CEO, QbD International, CGMP Consulting, United Nations Adviser.
President Museveni has praised Dei BioPharma Ltd for its groundbreaking work in producing life-saving vaccines and drugs, including treatment for cancer.
Revenue in Q4 2024 increased 45% to $13.53 billion driven by volume growth from Mounjaro and Zepbound. Non-incretin revenue(i) grew by 20% compared to Q4 2023. Pipeline ...
The first official version of the European quality assurance scheme for breast cancer services is now available on the European Commission web hub.
The biologics drug substance manufacturing market is witnessing substantial expansion, largely due to the growing prevalence of chronic disea ...
Serplulimab is the world's first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC Serplulimab is the first and only anti-PD-1 mAb approved in the European Union (EU) ...
Accomplished Leader to Oversee Quality and Compliance Across AIML's Global Operationsâ–ª Strengthens AIML's Commitment to Providing Reliable and Innovative AI-Powered Healthcare Solutions VANCOUVER, BC ...
Despite major advances in artificial intelligence (AI) research for healthcare, the deployment and adoption of AI technologies remain limited in clinical practice. This paper describes the FUTURE-AI ...
The proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback